Table 1.
Demographic/clinical characteristics and grey matter volume among schizophrenia with tardive dyskinesia, schizophrenia without tardive dyskinesia and normal control group.
Figure 1.
Regional gray matter volume atrophy pattern between disease groups and normal control group.
Figure 2.
Regions of reduced gray matter volume in schizophrenia with tardive dyskinesia group compared with schizophrenia without tardive dyskinesia group.
Table 2.
Gray matter anatomical regions with significant volume reduction in Schizophrenia with tardive dyskinesia group compared with Schizophrenia without tardive dyskinesia group.
Figure 3.
The relationship between clinical evaluations and regional gray natter reduction in disease groups.
Table 3.
Partial pearson correlation coefficients between clinical evaluations and reduced gray matter volume derived from the comparison of Schizophrenia with and without tardive dyskinesia groups.